van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, et al: The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002, 21 (2): 179-183. 10.1002/nau.10053.
Article
PubMed
Google Scholar
Johnson TM, Markland AD, Goode PS, Vaughan CP, Colli JL, Ouslander JG, Redden DT, McGwin G, Burgio KL: Efficacy of adding behavioural treatment or antimuscarinic drug therapy to alpha-blocker therapy in men with nocturia. BJU Int. 2013, 2013: 2013-
Google Scholar
Weiss JPBJ: Nocturnal polyuria versus overactive bladder in nocturia. Urology. 2002, 60 (5 Suppl 1): 28-32.
Article
PubMed
Google Scholar
Appell RASP: Nocturia: etiology, diagnosis, and treatment. Neurourol Urodyn. 2008, 27 (1): 34-39. 10.1002/nau.20484.
Article
PubMed
Google Scholar
Middelkoop HA, den Doel DA S-v, Neven AK, Kamphuisen HA, Springer CP: Subjective sleep characteristics of 1,485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci. 1996, 51 (3): M108-M115.
Article
CAS
PubMed
Google Scholar
Tsujimura A, Takao T, Miyagawa Y, Yamamoto K, Fukuhara S, Nakayama J, Kiuchi H, Suganuma N, Nakamura T, Kumano-Go T, et al: Urgency is an independent factor for sleep disturbance in men with obstructive sleep apnea. Urology. 2010, 76 (4): 967-970. 10.1016/j.urology.2010.01.070.
Article
PubMed
Google Scholar
Kim SO, Choi HS, Kim YJ, Kim HS, Hwang IS, Hwang EC, Oh KJ, Jung SI, Kang TW, Kwon D, et al: Impact of nocturia on health-related quality of life and medical outcomes study sleep score in men. Int Neurourol J. 2011, 15 (2): 82-86. 10.5213/inj.2011.15.2.82.
Article
PubMed
PubMed Central
Google Scholar
Kaye M: Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics. Can Urol Assoc J. 2008, 2 (6): 604-608.
PubMed
PubMed Central
Google Scholar
Drake MJ, Mills IW, Noble JG: Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004, 171 (3): 1199-1202. 10.1097/01.ju.0000110442.47593.ea.
Article
CAS
PubMed
Google Scholar
Shimizu NSK, Nozawa M: Efficacy of ramelteon in patients with insomnia and nocturia. LUTS. 2012, 10.1111/j.1757-5672.2012.00166.x. Epub ahead of print
Google Scholar
Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M: Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005, 48 (2): 301-310. 10.1016/j.neuropharm.2004.09.007.
Article
CAS
PubMed
Google Scholar
Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N: Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Med. 2011, 12 (2): 119-126. 10.1016/j.sleep.2010.08.010.
Article
PubMed
Google Scholar
Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimura N: Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep Med. 2011, 12 (2): 127-133. 10.1016/j.sleep.2010.10.006.
Article
PubMed
Google Scholar
Barry MJ, Williford WO, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT:The American Urological Association symptom indexfor benign prostatic hyperplasia. The measurement Committee of the American Urological Association. J Urol. 1992, 148 (5): 1549-1557.
CAS
PubMed
Google Scholar
Chapple C, Herschorn S, Abrams P, Sun F, Brodsky M, Guan Z: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol. 2009, 56 (3): 534-541. 10.1016/j.eururo.2008.11.026.
Article
CAS
PubMed
Google Scholar
Moore KN, Valiquette L, Chetner MP, Byrniak S, Herbison GP: Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy. Urology. 2008, 72 (6): 1280-1286. 10.1016/j.urology.2007.12.034.
Article
PubMed
Google Scholar
Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, et al: Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2009, 73 (4): 1023-1032. 10.1016/j.ijrobp.2008.05.022.
Article
PubMed
Google Scholar
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003, 61 (1): 37-49. 10.1016/S0090-4295(02)02243-4.
Article
PubMed
Google Scholar
Michel MC, Chapple CR: Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL). Eur Urol. 2006, 49 (3): 501-508. 10.1016/j.eururo.2005.12.024. discussion 508–509
Article
CAS
PubMed
Google Scholar
Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, Arai Y: Nocturia and benign prostatic hyperplasia. Urology. 2003, 61 (4): 786-790. 10.1016/S0090-4295(02)02444-5.
Article
PubMed
Google Scholar
Schwinn DA, Roehrborn CG: Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol. 2008, 15 (3): 193-199. 10.1111/j.1442-2042.2007.01956.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brawer MK, Lin DW, Williford WO, Jones K, Lepor H: Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. Prostate. 1999, 39 (4): 234-239. 10.1002/(SICI)1097-0045(19990601)39:4<234::AID-PROS3>3.0.CO;2-4.
Article
CAS
PubMed
Google Scholar
Homma Y, Araki I, Igawa Y, Ozono S, Gotoh M, Yamanishi T, Yokoyama O, Yoshida M: Clinical guideline for male lower urinary tract symptoms. Int J Urol. 2009, 16 (10): 775-790. 10.1111/j.1442-2042.2009.02369.x.
Article
PubMed
Google Scholar
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, et al: Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011, 185 (5): 1793-1803. 10.1016/j.juro.2011.01.074.
Article
PubMed
Google Scholar
Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society:: Clinical guidelines for nocturia. Int J Urol. 2010, 17 (5): 397-409.
Article
Google Scholar
Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T: 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986, 136 (3): 613-615.
CAS
PubMed
Google Scholar
Okada S, Watanabe H, Kojima Y, Yanai Y, Sasaki S, Kohri K: Loxoprofen sodium treatment for elderly men with refractory nocturia: effect on night-time urine production. Int J Urol. 2008, 15 (5): 462-464. 10.1111/j.1442-2042.2008.02021.x.
Article
CAS
PubMed
Google Scholar
Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, MacDonagh RP, Noble JG: Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004, 63 (3): 481-486. 10.1016/j.urology.2003.10.019.
Article
PubMed
Google Scholar
Klerman H, St Hilaire MA, Kronauer RE, Gooley JJ, Gronfier C, Hull JT, Lockley SW, Santhi N, Wang W, Klerman EB: Analysis method and experimental conditions affect computed circadian phase from melatonin data. PLoS One. 2012, 7 (4): e33836-10.1371/journal.pone.0033836.
Article
CAS
PubMed
PubMed Central
Google Scholar
Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O: Symptom assessment tool for overactive bladder syndrome–overactive bladder symptom score. Urology. 2006, 68 (2): 318-323. 10.1016/j.urology.2006.02.042.
Article
PubMed
Google Scholar
Gotoh M, Homma Y, Yokoyama O, Nishizawa O: Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology. 2011, 78 (4): 768-773. 10.1016/j.urology.2011.06.020.
Article
PubMed
Google Scholar
Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R: An epidemiological study of insomnia among the Japanese general population. Sleep. 2000, 23 (1): 41-47.
CAS
PubMed
Google Scholar
Liu X, Uchiyama M, Kim K, Okawa M, Shibui K, Kudo Y, Doi Y, Minowa M, Ogihara R: Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res. 2000, 93 (1): 1-11. 10.1016/S0165-1781(99)00119-5.
Article
CAS
PubMed
Google Scholar
Ramakrishnan K, Scheid DC: Treatment options for insomnia. Am Fam Physician. 2007, 76 (4): 517-526.
PubMed
Google Scholar
Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M: The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007, 22 (9): 1335-1350. 10.1007/s11606-007-0251-z.
Article
PubMed
PubMed Central
Google Scholar
Doghramji K: Melatonin and its receptors: a new class of sleep-promoting agents. J Clin Sleep Med. 2007, 3 (5 Suppl): S17-S23.
PubMed
PubMed Central
Google Scholar
Nowak JZ, Zawilska JB: Melatonin and its physiological and therapeutic properties. Pharm World Sci. 1998, 20 (1): 18-27. 10.1023/A:1008688724058.
Article
CAS
PubMed
Google Scholar
Takahashi S, Tajima A, Matsushima H, Kawamura T, Tominaga T, Kitamura T: Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia. Int J Urol. 2006, 13 (1): 15-20. 10.1111/j.1442-2042.2006.01222.x.
Article
CAS
PubMed
Google Scholar